Meningococcal Vaccines Market Size Was Valued at USD 3.73 Billion in 2023, and is Projected to Reach USD 8.80 Billion by 2032, Growing at a CAGR of 10.02% From 2024-2032. Market Overview Products for managing the vaccine that may offer protection against diseases caused by Neisseria meningitidis, a particular bacterium that causes extremely serious illnesses like meningitis or septicemia, are...